Global investors engage in potential $10m Healx Series A
The Business Weekly article also covers the appointment of Shaun Grady, a leading business development executive at Astra Zeneca, to Healx’s board of directors
News
Read the latest news about Healx and our goal to advance treatments for rare diseases.
Healx data scientist wins poster prize for finding new links between rare diseases
Erin Oerton, a PhD student at the University of Cambridge and data scientist at Healx, has won the poster prize for the Systems Medicine track at the 2nd Interdisciplinary Signalling Workshop in Visegrad, Hungary.
Healx Scientist publishes paper predicting effectiveness of combinations of antibiotics
Healx Scientist, Dan Mason, develops a machine learning approach to predict effectiveness of combinations of antibiotic treatments.
Healx listed as a Leading Global Innovator in ‘Disrupt 100’ list
Healx recognised as a venture with the potential to change the world we live in.
Healx CEO to speak at Milken Institute Global Conference
Tim Guilliams, Chief Executive Officer of Healx, invited to speak at the Milken Institute Global Conference
